OPTFSNA
CBIO

Old Point Trust & Financial Services N A’s Crescent Biopharma CBIO Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$1.5K – 420
2024
Q1 		$1.5K Buy
+5
New +$1.49K ﹤0.01% 450

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Old Point Trust & Financial Services N A's CBIO Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of Crescent Biopharma (CBIO) in Q2 2024, closing a stake of 5 shares — an estimated $1.5K sold.

Old Point Trust & Financial Services N A first reported a position in CBIO in Q1 2024 and held it in 1 quarter. The position peaked at $1.5K in Q1 2024. 35 funds tracked by Wall St. Rank hold CBIO as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining Crescent Biopharma position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 5 Crescent Biopharma shares in Q2 2024, an estimated $1.5K.
  • Old Point Trust & Financial Services N A first reported a position in Crescent Biopharma in Q1 2024 and held it in 1 quarter.
  • Old Point Trust & Financial Services N A's Crescent Biopharma position peaked at $1.5K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.